Vertex Pharmaceuticals Incorporated Forecast and Target Price
$447.11
Vertex Pharmaceuticals Incorporated (VRTX) Share Price Forecast
Currently 38 wall-street analysts regularly analyze the financials of Vertex Pharmaceuticals Incorporated on a frequent basis to provide recommendations along with target share price. 38 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Incorporated (VRTX) have a share price target of $547.72. This median of share price forecast represents a 22.5% upside from the latest price of $447.11 as on 02.04.26.
Vertex Pharmaceuticals Incorporated (VRTX) Price vs Consensus Price Target
As per the chart shown above, analysts believe that the Vertex Pharmaceuticals Incorporated (VRTX) share price will touch around $547.72 in next 12-months.
Vertex Pharmaceuticals Incorporated (VRTX) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Vertex Pharmaceuticals Incorporated's share price and its median forecast price. As on 02.04.26, the difference is -18.34%